Scilex Holding Co SEC filings SCLX
Scilex Holding Co has 742 filings in SEC EDGAR's recent list, going back to Aug 19, 2020. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Sep 29, 2026 | Sep 25, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 24, 2026 | — |
| 4 | Insider transaction | Aug 24, 2026 | Aug 20, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 12, 2026 | Aug 8, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Jul 22, 2026 | Jul 18, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 7, 2026 | — |
| 4 | Insider transaction | Jul 7, 2026 | Jul 3, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 6, 2026 | Jul 3, 2026 |
| S-8 | Employee stock plan registration | Jun 30, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 29, 2026 | Jun 24, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 26, 2026 | — |
| 4 | Insider transaction | Jun 26, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2026 | Jun 24, 2026 |
| EFFECT | Filing | Jun 11, 2026 | — |
| CORRESP | Letter to the SEC | Jun 9, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2026 | — |
| S-3 | Shelf registration | Jun 2, 2026 | — |
| EFFECT | Filing | May 22, 2026 | — |
| 10-Q | Quarterly report | May 20, 2026 | Mar 31, 2026 |
| CORRESP | Letter to the SEC | May 20, 2026 | — |
| NT 10-Q | Filing | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Other events
|
May 11, 2026 | May 11, 2026 |
| DEFA14A | Additional proxy material | May 5, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 5, 2026 | May 4, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 24, 2026 |
| CORRESP | Letter to the SEC | Apr 30, 2026 | — |
| 8-K |
Current report
Material agreement
|
Apr 28, 2026 | Apr 26, 2026 |
| UPLOAD | Letter from the SEC | Apr 24, 2026 | — |
| 4 | Insider transaction | Apr 20, 2026 | Apr 17, 2026 |
| 4 | Insider transaction | Apr 20, 2026 | Apr 16, 2026 |
| S-3 | Shelf registration | Apr 16, 2026 | — |
| 10-K | Annual report | Apr 10, 2026 | Dec 31, 2025 |
| NT 10-K | Filing | Apr 1, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2026 | Mar 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2026 | Mar 13, 2026 |
| 424B3 | Prospectus | Feb 23, 2026 | — |
| 424B3 | Prospectus | Feb 23, 2026 | — |
| 424B3 | Prospectus | Feb 23, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 20, 2026 | Feb 19, 2026 |
| UPLOAD | Letter from the SEC | Feb 20, 2026 | — |
| DRS | Filing | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| S-8 | Employee stock plan registration | Feb 9, 2026 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Feb 3, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Material agreement
|
Feb 2, 2026 | Jan 29, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 14, 2026 | — |
| 4 | Insider transaction | Jan 14, 2026 | Jan 12, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 8, 2026 | — |
| 4 | Insider transaction | Jan 8, 2026 | Jan 6, 2026 |
| RW | Filing | Jan 6, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 31, 2025 | — |
| 4/A | Filing | Dec 31, 2025 | Dec 26, 2025 |
| 4 | Insider transaction | Dec 30, 2025 | Dec 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 30, 2025 | Dec 30, 2025 |
| EFFECT | Filing | Dec 29, 2025 | — |
| 424B3 | Prospectus | Dec 29, 2025 | — |
| CORRESP | Letter to the SEC | Dec 23, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 22, 2025 | Dec 22, 2025 |
| 424B3 | Prospectus | Dec 17, 2025 | — |
| 424B3 | Prospectus | Dec 17, 2025 | — |
| 424B3 | Prospectus | Dec 17, 2025 | — |
| 8-K |
Current report
Material agreement, New debt
|
Dec 17, 2025 | Dec 16, 2025 |
| S-1 | Registration statement | Dec 16, 2025 | — |
| 424B3 | Prospectus | Dec 12, 2025 | — |
| 424B3 | Prospectus | Dec 12, 2025 | — |
| 424B3 | Prospectus | Dec 12, 2025 | — |
| 8-K |
Current report
Material agreement, New debt
|
Dec 12, 2025 | Dec 8, 2025 |
| 424B3 | Prospectus | Dec 11, 2025 | — |
| 424B3 | Prospectus | Dec 11, 2025 | — |
| 424B3 | Prospectus | Dec 11, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 11, 2025 | Dec 11, 2025 |
| 424B3 | Prospectus | Dec 5, 2025 | — |
| 424B3 | Prospectus | Dec 5, 2025 | — |
| 424B3 | Prospectus | Dec 5, 2025 | — |
| 8-K |
Current report
Material agreement, New debt
|
Dec 5, 2025 | Dec 1, 2025 |
| UPLOAD | Letter from the SEC | Dec 4, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Dec 1, 2025 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
Dec 1, 2025 | Nov 25, 2025 |
| 4 | Insider transaction | Nov 28, 2025 | Nov 25, 2025 |
| 3 | Initial insider ownership | Nov 28, 2025 | Nov 25, 2025 |
| 424B3 | Prospectus | Nov 24, 2025 | — |
| 424B3 | Prospectus | Nov 24, 2025 | — |
| 424B3 | Prospectus | Nov 24, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 24, 2025 | Nov 23, 2025 |
| 424B3 | Prospectus | Nov 14, 2025 | — |
| 424B3 | Prospectus | Nov 14, 2025 | — |
| 424B3 | Prospectus | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| DEF 14A | Proxy statement | Nov 7, 2025 | Dec 11, 2025 |
| 424B3 | Prospectus | Nov 4, 2025 | — |
| 424B3 | Prospectus | Nov 4, 2025 | — |
| 424B3 | Prospectus | Nov 4, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 4, 2025 | Nov 3, 2025 |
| 424B3 | Prospectus | Oct 31, 2025 | — |
| 424B3 | Prospectus | Oct 31, 2025 | — |
| 424B3 | Prospectus | Oct 31, 2025 | — |
| 8-K |
Current report
Agreement ended
|
Oct 31, 2025 | Oct 30, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 28, 2025 | Dec 11, 2025 |
| D | Filing | Oct 14, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 14, 2025 | — |
| 4 | Insider transaction | Oct 9, 2025 | Oct 8, 2025 |
| 4 | Insider transaction | Oct 9, 2025 | Oct 8, 2025 |
| 4 | Insider transaction | Oct 9, 2025 | Oct 8, 2025 |
| 4 | Insider transaction | Oct 9, 2025 | Oct 8, 2025 |
| 4 | Insider transaction | Oct 9, 2025 | Oct 8, 2025 |
| 424B3 | Prospectus | Oct 7, 2025 | — |
| 424B3 | Prospectus | Oct 7, 2025 | — |
| 424B3 | Prospectus | Oct 7, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Oct 7, 2025 | Oct 1, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Oct 2, 2025 | — |
| 424B3 | Prospectus | Oct 2, 2025 | — |
| 424B3 | Prospectus | Oct 2, 2025 | — |
| 424B3 | Prospectus | Oct 2, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 1, 2025 | Sep 30, 2025 |
| 424B3 | Prospectus | Sep 29, 2025 | — |
| 424B3 | Prospectus | Sep 29, 2025 | — |
| 424B3 | Prospectus | Sep 29, 2025 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
Sep 26, 2025 | Sep 25, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Sep 26, 2025 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure, Other events
|
Sep 26, 2025 | Sep 23, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 26, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 25, 2025 | Sep 23, 2025 |
| 3 | Initial insider ownership | Sep 23, 2025 | Sep 22, 2025 |
| CORRESP | Letter to the SEC | Aug 29, 2025 | — |
| 424B3 | Prospectus | Aug 21, 2025 | — |
| 424B3 | Prospectus | Aug 21, 2025 | — |
| 424B3 | Prospectus | Aug 21, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Aug 21, 2025 | Aug 16, 2025 |
| UPLOAD | Letter from the SEC | Aug 20, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 424B3 | Prospectus | Aug 14, 2025 | — |
| 424B3 | Prospectus | Aug 14, 2025 | — |
| 424B3 | Prospectus | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| S-1 | Registration statement | Aug 4, 2025 | — |
| 424B3 | Prospectus | Jul 23, 2025 | — |
| 424B3 | Prospectus | Jul 23, 2025 | — |
| 424B3 | Prospectus | Jul 23, 2025 | — |
| 8-K |
Current report
Material agreement
|
Jul 23, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 23, 2025 | Jul 22, 2025 |
| 424B3 | Prospectus | Jun 24, 2025 | — |
| 424B3 | Prospectus | Jun 24, 2025 | — |
| 424B3 | Prospectus | Jun 24, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 23, 2025 | Jun 23, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 4, 2025 | Jun 4, 2025 |
| ARS | Annual report to shareholders | May 16, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | May 16, 2025 | Jun 4, 2025 |
| 424B3 | Prospectus | May 15, 2025 | — |
| 424B3 | Prospectus | May 15, 2025 | — |
| 424B3 | Prospectus | May 15, 2025 | — |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 424B3 | Prospectus | May 14, 2025 | — |
| 424B3 | Prospectus | May 14, 2025 | — |
| 424B3 | Prospectus | May 14, 2025 | — |
| EFFECT | Filing | May 13, 2025 | — |
| EFFECT | Filing | May 13, 2025 | — |
| EFFECT | Filing | May 13, 2025 | — |
| 8-K |
Current report
Officer or director change
|
May 12, 2025 | May 9, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 8, 2025 | — |
| POS AM | Filing | May 7, 2025 | — |
| POS AM | Filing | May 7, 2025 | — |
| POS AM | Filing | May 7, 2025 | — |
| 8-K |
Current report
Other events
|
Apr 30, 2025 | Apr 30, 2025 |
| 10-K/A | Amended annual report | Apr 29, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 22, 2025 | Apr 22, 2025 |
| 8-K |
Current report
Material agreement
|
Apr 21, 2025 | Apr 16, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Apr 15, 2025 | Apr 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 11, 2025 | Apr 11, 2025 |
| S-8 | Employee stock plan registration | Apr 1, 2025 | — |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 424B3 | Prospectus | Mar 20, 2025 | — |
| 424B3 | Prospectus | Mar 20, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Mar 20, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2025 | Mar 10, 2025 |
| 424B3 | Prospectus | Mar 5, 2025 | — |
| 424B3 | Prospectus | Mar 3, 2025 | — |
| 424B3 | Prospectus | Mar 3, 2025 | — |
| 8-K |
Current report
Agreement ended
|
Mar 3, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 3, 2025 | Feb 28, 2025 |
| 424B3 | Prospectus | Feb 27, 2025 | — |
| 424B3 | Prospectus | Feb 27, 2025 | — |
| DEF 14A | Proxy statement | Feb 27, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Material agreement
|
Feb 27, 2025 | Feb 22, 2025 |
| PRER14A | Filing | Feb 26, 2025 | — |
| PRE 14A | Preliminary proxy statement | Feb 14, 2025 | Mar 19, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 23, 2025 | — |
| 4 | Insider transaction | Jan 23, 2025 | Jan 21, 2025 |
| 424B3 | Prospectus | Jan 22, 2025 | — |
| 424B3 | Prospectus | Jan 22, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 22, 2025 | Jan 21, 2025 |
| 424B3 | Prospectus | Jan 21, 2025 | — |
| 424B3 | Prospectus | Jan 21, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 21, 2025 | Jan 21, 2025 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SCLX (Nasdaq), SCLXW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Palo Alto, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1820190
- Former names
- Scilex Holding Company/DE (until Nov 30, 2022); Vickers Vantage Corp. I (until Nov 15, 2022)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.